NCT01018732View on ClinicalTrials.gov

A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY

PHASE2CompletedINTERVENTIONAL

Enrollment

155

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Meningococcal DiseaseMeningococcal Meningitis

Interventions

BIOLOGICAL

Novartis Meningococcal (MenACWY-CRM) vaccine

All subjects will have blood draws at Day 1, Day 8, and Day 29.

Trial Locations (3)

Unknown

Rochester

Pittsburgh

Seattle

Sponsors

Lead Sponsor

Novartis Vaccines

Collaborators (1)

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY

collaborator

Novartis

INDUSTRY